Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Shehab N, Brown MN, Kallen AJ, Perz JF.

J Patient Saf. 2015 May 21. [Epub ahead of print]

2.

Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.

Gupta N, Hocevar SN, Moulton-Meissner HA, Stevens KM, McIntyre MG, Jensen B, Kuhar DT, Noble-Wang JA, Schnatz RG, Becker SC, Kastango ES, Shehab N, Kallen AJ.

Clin Infect Dis. 2014 Jul 1;59(1):1-8. doi: 10.1093/cid/ciu218. Epub 2014 Apr 11.

3.

Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.

Weissfeld AS, Joseph RA, Le TV, Trevino EA, Schaeffer MF, Vance PH.

J Clin Microbiol. 2013 Oct;51(10):3172-5. doi: 10.1128/JCM.00944-13. Epub 2013 Jul 31.

4.

Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Staes C, Jacobs J, Mayer J, Allen J.

Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049. Review.

5.

Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases.

Ritter JM, Muehlenbachs A, Blau DM, Paddock CD, Shieh WJ, Drew CP, Batten BC, Bartlett JH, Metcalfe MG, Pham CD, Lockhart SR, Patel M, Liu L, Jones TL, Greer PW, Montague JL, White E, Rollin DC, Seales C, Stewart D, Deming MV, Brandt ME, Zaki SR; Exserohilum Infections Working Group.

Am J Pathol. 2013 Sep;183(3):881-92. doi: 10.1016/j.ajpath.2013.05.007. Epub 2013 Jun 26.

6.

Straight from the headlines: what is going on in compounding pharmacies, and how can clinical microbiologists help?

Weissfeld AS.

J Clin Microbiol. 2013 Oct;51(10):3168-71. doi: 10.1128/JCM.00160-13. Epub 2013 Jun 19. Review. No abstract available.

7.

Potential risks of pharmacy compounding.

Gudeman J, Jozwiakowski M, Chollet J, Randell M.

Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9. Review.

8.

Fungal infections associated with contaminated methylprednisolone in Tennessee.

Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, Park BJ, Kanago ML, Baumblatt J, Schaefer MK, Berger BE, Marder EP, Min JY, Dunn JR, Smith RM, Dreyzehner J, Jones TF; Tennessee Fungal Meningitis Investigation Team.

N Engl J Med. 2012 Dec 6;367(23):2194-203. doi: 10.1056/NEJMoa1212972. Epub 2012 Nov 6.

9.

Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.

Warner T, Nishi C, Checkowski R, Hall KW.

Can J Hosp Pharm. 2009 Mar;62(2):100-11.

10.

Serratia infections: from military experiments to current practice.

Mahlen SD.

Clin Microbiol Rev. 2011 Oct;24(4):755-91. doi: 10.1128/CMR.00017-11. Review.

11.

Performance improvement in pharmacy education.

Chambers SL.

Am J Pharm Educ. 2010 May 12;74(4):64. No abstract available.

12.

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK.

Clin Infect Dis. 2009 Jul 1;49(1):1-45. doi: 10.1086/599376. No abstract available. Erratum in: Clin Infect Dis. 2010 Apr 1;50(7):1079. Dosage error in article text. Clin Infect Dis. 2010 Feb 1;50(3):457.

13.
14.

Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl.

Maragakis LL, Chaiwarith R, Srinivasan A, Torriani FJ, Avdic E, Lee A, Ross TR, Carroll KC, Perl TM.

Emerg Infect Dis. 2009 Jan;15(1):12-8. doi: 10.3201/eid1501.081054.

Supplemental Content

Support Center